Organizing Committee
Biography
Dr Vickie R. Driver is a Fellow at the American College of Foot and Ankle Surgeons, licensed in Ma and RI and is board certified in foot surgery by the American Board of Podiatric Surgery. She has recently been nominated as Fellow, Royal College of Physicians and Surgeons-Glasgow, PM. Her career has a special emphasis on wound healing and limb preservation and she is an outspoken ambassador for progressive change in this field. Dr. Driver is a Professor of Surgery in the Department of Orthopedics at Brown University (Clinical). She has recently completed her tenure as president for the Advancement of Wound Care Association (AAWC), and has served for 9 years on the Board of Directors. She also proudly serves as a member of the Wound Healing Society (WHS) Board of Directors- member at large and chair-Industry relations and as member Board of Directors for the Critical Limb Ischemia (CLI) Global Society and chair wound healing committee. She has successfully chaired an initiative to expand the wound healing clinical endpoints considered by FDA. She proposed a combined effort between the WHS and AAWC to develop the Wound-care Experts/FDA-Clinical Endpoints Project [WEF-CEP] to strategically identify clinically meaningful, evidence-based and patient-centered wound care endpoints that are relevant for clinical research and trials. The goal is to collaboratively work with the FDA to expand the list of acceptable primary endpoints, recognizing that new and innovative treatments, devices and drugs may not have complete healing as the focus. Furthermore, validated endpoints other than complete healing will promote improved clinical trial design and will reduce the time for discoveries to reach our patients. Over the past three years, through ongoing interaction with the FDA InterCenter Wound Healing Work Group [ICWHWG], the WEF-CEP team has conducted a wide reaching Clinician Survey with 628 participating wound care experts, completed an extensive literature review for 28 wound care endpoints using the FDA criteria for a validated endpoint, published the clinical survey results in WRR, is in process to publish the research phase results and is currently conducting a Patient Survey to augment the findings of the Clinician Survey. Formal collaboration with the FDA established to execute on the WEF CEP work is on-going. As principle investigator, she has served on and initiated more than 70 important multi-center randomized clinical trials, as well as developed and supervised multiple research fellowship training programs. She has co-authored over 100 publications and abstracts. Dr. Driver is Director, Translational Medicine Wound Healing at Novartis Institute for BioMedical Research. She is dedicated to making a scientific contribution to both the understanding of the natural history of disease and the discovery of new therapies and diagnostics to advance the treatment of patients who suffer with wounds and are at risk of limb loss. .
Research Interest
wound healing and limb preservation
Biography
Ms. Kirkland-Walsh received her NP degree as a Family/Geriatric Nurse Practitioner from the University of California, Davis, her BSN and MSN degrees from Cal State, Sacramento, and a WOCN certification from the University of Washington, Seattle. She has served as Nurse Manager in the Medical Surgical Unit / Geriatrics and as Diabetes Educator and Clinical Trials Nurse in Waterford, Ireland, as a Palliative Care Nurse at Kaiser, and as Cardiology Nurse Practitioner at UCDMC. She Completed her PhD in Nursing at the University of California San Francisco. Since 2004, Ms. Kirkland-Walsh has been a board member for the Sacramento Community Clinics Consortium. She presently serves as an Urgent Care Nurse Practitioner at Kaiser, as Assistant Medical Director at The Effort Indigent Health Clinic, and as Wound Care Nurse Practitioner at University of California, Davis Health System in Sacramento, CA. In the latter role, she leads a multidisciplinary team that focuses on the prevention and treatment of chronic wounds. In addition to these various positions, Ms. Kirkland-Walsh has worked with geriatric patients in Ireland, Great Britain, and, most recently, in Haiti where she did disaster relief work as a volunteer for Medishare and served as Chief Medical Officer at the Bernard Mevs Hospital, the only acute care hospital in Haiti. She also comes with prior teaching experience, serving as clinical faculty for Nurse Practitioner programs at University of California, Davis, University of California, San Francisco, Sonoma State, University of Phoenix, and Samuel Merritt. Her proposed area of research focuses on perfusion related pressure ulcers and the comparison on hospital acquired pressure ulcers to community acquired pressure ulcers.
Research Interest
Ulcers, Wound Care,Skin
Biography
Naiem Moiemen, MB BS, MSc, FRCS (Plast) is an Honorary Professor at the University of Birmingham and a consultant plastic and burns surgeon at University Hospital Birmingham. He is Director of the Scar Free Foundation Centre for Burn Research in Birmingham He is the Clinical Lead of the Midland Burns Care Network, serving a population of 10 million. Naiem is Immediate Past President of European Burn Association Executive, President-Elect of the International Association of Burn Injury (ISBI) and past Chairman of the British Burn Association (BBA). He is supervising 3 PhD students and current chief investigator of 4 current multi-centre burns clinical trials: NIHR-HTA pressure garment pilot efficacy multi-centre trial, and the SIFTI trial investigating the acute response to burn injury and HESTIA trial investigating gut translocation following thermal injury. He is also PI on the Wellcome-NIHR HICF to develop an anti-scarring wound dressing, and recently £4.5m Libor Grant fund to establish a scar and wound healing research centre in Birmingham. He has published more than 90 papers in peer review journals and book chapters. He is a senior editor of BURNS journal and deputy editor of Journal of Burn and Trauma.
Research Interest
Scars, Wound Healing, Burns, Burn Injury
Biography
Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School. He completed his residency in Surgery at The Milton S. Hershey Medical Center with additional year of training in Plastic and Reconstructive Surgery at Southern Illinois University. To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings. He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association. Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.
Research Interest
wound and hyperbaric research